| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/29/2011 | CN102106417A Dandelion health-preservation tea |
| 06/29/2011 | CN101912581B Chinese medicinal composition for treating cholecystitis and calculosis and preparation method thereof |
| 06/29/2011 | CN101869675B Chinese medicinal composition granules for treating summer-heat damp cold and preparation method thereof |
| 06/29/2011 | CN101862415B Health liquor |
| 06/29/2011 | CN101744815B Composite medicament of omeprazole sodium |
| 06/29/2011 | CN101732694B Medicament for treating chronic diarrhea |
| 06/29/2011 | CN101721674B Traditional Chinese medicine combination for treating gastropathy |
| 06/29/2011 | CN101708237B Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof |
| 06/29/2011 | CN101700278B Composition for treating liver injury |
| 06/29/2011 | CN101695560B Chinese medicinal composition for treating concrement |
| 06/29/2011 | CN101653552B Smoke-quitting alexeteric traditional Chinese medicine preparation and production method thereof |
| 06/29/2011 | CN101653539B Traditional Chinese medicine for treating oral diseases |
| 06/29/2011 | CN101642550B Plaster for treating chronic gastroenteritis and preparation method thereof |
| 06/29/2011 | CN101642483B Microwave treatment and storage method of snakegourd fruits |
| 06/29/2011 | CN101627969B Novel curcumin self-emulsifying drug delivery system and preparation method thereof |
| 06/29/2011 | CN101607067B Traditional Chinese medicine preparation for treating cholelithiasis and preparation method thereof |
| 06/29/2011 | CN101584750B Compound fig preparation |
| 06/29/2011 | CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
| 06/29/2011 | CN101548757B Insoluble dietary fiber of raisin tree and preparing method thereof |
| 06/29/2011 | CN101537151B Pharmaceutical composition having effects of alleviating alcoholism, protecting liver, invigorating stomach and clearing bowels |
| 06/29/2011 | CN101524481B Chinese herbal compound for preventing and curing fatty liver |
| 06/29/2011 | CN101518580B Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
| 06/29/2011 | CN101455769B Chinese medicine for treating constipation |
| 06/29/2011 | CN101444563B Usage of cherokee rose root extract |
| 06/29/2011 | CN101411777B Desert cistanche mixture for moistening intestines |
| 06/29/2011 | CN101411392B Chinese herbal medicine additive agent for preventing and treating pig viral enteritis |
| 06/29/2011 | CN101407534B 2'-fluoro-4'-substituted-nucleoside analogue and use thereof |
| 06/29/2011 | CN101376001B Pure medicinal formulation for strengthening spleen and regulating stomach and preparation method thereof |
| 06/29/2011 | CN101357930B Adefovir dipivoxil preparation method |
| 06/29/2011 | CN101327293B Capsules for treating peptic ulcer and preparation method thereof |
| 06/29/2011 | CN101259196B Chinese medicinal composition for treating gastric ulcer |
| 06/29/2011 | CN101239110B Prepared Chinese medicine capsule and its preparation and quality control method |
| 06/29/2011 | CN101095896B Chinese traditional medicine composition for treating cholecyst disease and fingerprint pattern analyzing method thereof |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968710 Prokineticin 1 receptor antagonists |
| 06/28/2011 | US7968596 Preparation and diabetic use of Gibberellins |
| 06/28/2011 | US7968559 Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968118 Anti-acid pharmaceutical composition in powder form and process for making it |
| 06/28/2011 | CA2506603C Nutritional compositions |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2465832C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/28/2011 | CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |
| 06/23/2011 | WO2011075607A1 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | WO2011074670A1 Liquid food composition |
| 06/23/2011 | WO2011074608A1 Prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011074607A1 Triterpene derivative, and prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011073447A1 Emd c-depleted |
| 06/23/2011 | WO2011072623A1 Benzomacrolides with pancreatic lipase inhibition, methods of preparation and uses thereof |
| 06/23/2011 | WO2011017554A3 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152375 Method of reducing the methane gas level and of increasing the total gas yield in animal feed |
| 06/23/2011 | US20110152367 Process for the preparation of fesoterodine with low impurities content |
| 06/23/2011 | US20110152363 Organically chelated mineral compositions and methods thereof |
| 06/23/2011 | US20110152338 Cycloalkane[b]indole antagonists of prostaglandin d2 receptors |
| 06/23/2011 | US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 06/23/2011 | US20110152321 Bicyclic derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152320 Pyrrole derivatives, their preparation and their therapeutic application |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152314 Use of tenatoprazole for the treatment of gastroesophageal reflux disease |
| 06/23/2011 | US20110152299 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152293 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 06/23/2011 | US20110152287 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152280 Novel ergoline analogs |
| 06/23/2011 | US20110152261 Organic compounds |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152225 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152207 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/23/2011 | US20110152186 Glucagon-like-peptide-2 (glp-2) analogues |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151001 Pharmaceutical composition for external application containing prochlorperazine |
| 06/23/2011 | US20110150945 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150855 Enzyme Composition and Use Thereof |
| 06/23/2011 | US20110150853 Mycotoxin-reducing composition |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150831 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/23/2011 | US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 06/23/2011 | US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |